MedPath

Nicotine Delivery Systems: Research & Treatment

Not Applicable
Terminated
Conditions
Smoking
Interventions
Drug: Nicotine gum - 2 mg and 4 mg
Other: Computer learning
Drug: Nicotine lozenges - 2 mg and 4 mg
Drug: Nicotine inhaler (4 mg yield) - low and high "dosage" by frequency of puffing
Registration Number
NCT00108342
Lead Sponsor
US Department of Veterans Affairs
Brief Summary

The purpose of this study is to determine whether sampling nicotine replacement treatments (NRTs) is superior to learning about them by computer. Testing also covers preferences among the treatments. Subjects will be enrolled veterans who smoke.

Hypothesis: Direct experience ("sampling") of NRTs will increase knowledge about NRTs, motivation/confidence, use of NRTs and quit attempts in contrast to learning about NRTs by computer.

Detailed Description

The study was designed to compare sampling of several nicotine replacement treatments (NRTs) in contrast to a computer learning control. The NRTs include: 2 dosages of nicotine gum, 2 dosages of nicotine lozenges and 2 dosages of oral nicotine inhalers. In the sampling group, each participant tries each of the 6 NRTs for 3 minutes. In the control, the individuals read about the treatments. Dependent measures include: quit attempts, use of NRTs, preferences among NRTs, and learning and motivation.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Must be enrolled veteran who smokes.
Read More
Exclusion Criteria
  • Any event or condition that could be exacerbated by the local effects of nicotine treatments (e.g., throat or stomach problems; any kind of wheezing from a condition or medication)
  • other criteria as determined by PI and study physicians
  • reactions to menthol (inhaler) or to aspartame (lozenge)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Nicotine Replacement Treatment (NRT) SamplingNicotine gum - 2 mg and 4 mgSampling = 3 minute testing of each of 6 NRTs (3 forms x 2 dosages) 2 mg and 4 mg nicotine gum; 2 mg and 4 mg nicotine lozenges; frequent and infrequent puffing on a nicotine inhaler (can yield 4 mg from 10 mg device).
Nicotine Replacement Treatment (NRT) SamplingNicotine lozenges - 2 mg and 4 mgSampling = 3 minute testing of each of 6 NRTs (3 forms x 2 dosages) 2 mg and 4 mg nicotine gum; 2 mg and 4 mg nicotine lozenges; frequent and infrequent puffing on a nicotine inhaler (can yield 4 mg from 10 mg device).
Nicotine Replacement Treatment (NRT) SamplingNicotine inhaler (4 mg yield) - low and high "dosage" by frequency of puffingSampling = 3 minute testing of each of 6 NRTs (3 forms x 2 dosages) 2 mg and 4 mg nicotine gum; 2 mg and 4 mg nicotine lozenges; frequent and infrequent puffing on a nicotine inhaler (can yield 4 mg from 10 mg device).
NRT Computer LearningComputer learningComputer learning: learning about 6 NRTs (3 forms x 2 dosages) by computer only
Primary Outcome Measures
NameTimeMethod
Quit Attempts, Use of NRTs, Preference Among NRTsAt testing, at follow-up

In addition to quit attempts, use of NRTs, and preference among NRTs, we also planned to assess learning and changes in motivation at all visits. Unfortunately, the study was terminated due to common comorbidities among the Veterans that precluded entry into the study. Due to the consequent small sample size, we did not analyze any data.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

VA Greater Los Angeles Healthcare System, West LA

🇺🇸

West Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath